Novel immunotherapy against several tumors including neuronal and brain tumors

摘要

Disclosed is a peptide consisting of the amino acid sequence of SEQ ID NO: 20 (KIISEIQAL), or a pharmaceutically acceptable salt thereof. Further disclosed is a fusion protein comprising the peptide of SEQ ID NO: 20 adjoined at the N-terminus and/or the C-terminus by one or more heterologous peptides, or a pharmaceutically acceptable salt thereof.